Saturday, December 9, 2017
7:30 AM - 4:00 PM
DoubleTree by Hilton Miami Airport & Convention Center
711 North West 72nd Avenue
Miami, FL 33126
Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.
HMS aims to provide important educational updates from leading experts on conditions that are commonly encountered by healthcare providers practicing in the hospital-setting, including chronic obstructive pulmonary disease, heart failure, hepatic encephalopathy, interstitial lung disease, and invasive fungal infections. Now is a critical time for practitioners to align their practices in anticipation of current and future changes in healthcare policy that will affect payment for services in this setting.
Going Green Initiative
In an effort to conserve and reduce the use of paper, participant materials for HMS will only be available electronically. Participants are encouraged to bring their laptops, tablets, or other wifi-enabled mobile devices. Wireless high speed Internet will be provided free of charge.
7:30 AM – 8:00 AM Registration/Breakfast Served
8:00 AM – 9:00 AM Keynote: Impacting Transitions of Care and Readmission
Alpesh Amin, MD
9:00 AM – 10:15 AM Addressing Challenges to Optimal Diagnosis and Treatment of Invasive Fungal Infections
John R. Perfect, MD
10:15 AM – 10:30 AM Break
10:30 AM – 11:45 AM Opportunities to Individualize Treatment and Alter the Course of Interstitial Lung Disease
Marilyn Glassberg Csete, MD
11:45 AM – 12:00 PM Lunch Served
12:00 PM – 1:15 PM Improving Outcomes of Patients with Heart Failure: Implementation of Guideline-Directed Medical Therapy and Effective Transitions of Care
Corey Tabit, MD
1:15 PM – 2:30 PM Reducing Readmissions for COPD Through Collaborative Evidence-based Care
Alpesh Amin, MD
2:30 PM – 2:45 PM Break
2:45 PM – 4:00 PM Reducing the Hospital Burden of Hepatic Encephalopathy Through Secondary Prophylaxis
Don C. Rockey, MD
4:00 PM Closing Remarks
This educational initiative has been designed for hospital-based healthcare providers, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists.
This educational activity for 7.25 contact hour(s) is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Impacting Transitions of Care and Readmission Session
- Identify the challenges with transitions of care in healthcare
- Assess readmission challenges
- Describe the quality and economic impact of transitions of care and readmissions
- Review evidence based strategies and opportunities to improve transitions of care and readmissions
Invasive Fungal Infections Session
- Identify the limitations to diagnosing the three most common fungal organisms causing fungal infections and recognize when empiric treatment should be initiated in patients
- Review the emerging resistance patterns of fungal infections and the mechanisms that fungal species use to develop resistance
- Discuss updated invasive fungal treatment guidelines and how to apply the recommendations in the clinical setting
Interstitial Lung Disease (ILD) Session
Heart Failure (HF) Session
- Outline a multidisciplinary approach for the differential diagnosis of ILD
- Discuss the latest evidence-based guidelines for IPF and review strategies for individualized management of patient with ILD
- Describe strategies for ensuring adequate communication between clinician and patient over the course of ILD management
- Outline an approach to the diagnosis and evaluation of patients with HF that is consistent with evidence-based guidelines
- Identify the mechanisms of action of new pharmacologic therapies for the treatment of heart failure with ejection fraction (HFrEF) and describe the clinical evidence regarding their efficacy and safety
- Implement guideline-directed medical therapy for patients with HF
- Describe effective strategies for improving transitional care to achieve guideline-directed medical therapy (GDMT) and prevent future hospitalization of patients with HF
Chronic Obstructive Pulmonary Disease (COPD) Session
- Describe long-term management strategies that may reduce COPD-related hospital readmissions
- Review important comorbidities of COPD as a part of a management strategy to reduce readmissions
- Incorporate cognitive and physical assessments during inpatient stays and outpatient visits to determine the appropriate device for patients with COPD
- Improve communication between inpatient and outpatient healthcare providers who manage patients with COPD to better coordinate care transitions
Hepatic Encephalopathy (HE) Session
- Describe the burden and need to prevent recurrence and re-hospitalizations for overt HE
- Evaluate the efficacy and safety of available and emerging agents for secondary prophylaxis of HE
- Develop a multidimensional management plan that includes long-term treatment strategies, as well as non-pharmacologic strategies, to care for patients with HE
A detailed disclosure for all persons in control of content, including faculty presenters, will be provided at the live event.
Physician Continuing Education
Physician Accreditation Statement
Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Integrity Continuing Education designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Pharmacist Continuing Education
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 7.25 contact hour(s) (0.725 CEUs) of the Accreditation Council for Pharmacy Education.
This is a knowledge based activity.
Hospital Medicine Summit Universal Activity Number: 0530-9999-17-345-L01-P
Instructions to Receive Credit
Pharmacists: To receive credits for participating in the 2017 Hospital Medicine Summit, participants must attend the live program on Saturday, December 9, 2017 in Miami, Florida and complete the evaluation form provided on-site. Upon receipt of a completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks of completion.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A statement of credit will be issued only upon receipt of a completed activity evaluation form.
For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or firstname.lastname@example.org.
For information about ACPE or ANCC accreditation of this activity, please contact Global at (303) 395-1782 or email@example.com.
Americans with Disabilities Act
Event staff will be glad to assist you. Please contact Integrity Continuing Education, Inc. prior to the live event at (855) 835-4004.
Disclosure of Conflicts of Interest (COI)
Integrity Continuing Education requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Integrity Continuing Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
This CME activity is provided by Integrity Continuing Education.
This CEU/CNE activity is jointly provided by Global Education Group and Integrity Continuing Education.
This activity is supported by independent educational grants from Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Mylan Specialty L.P., Novartis Pharmaceuticals Corporation, and Sunovion Pharmaceuticals, Inc.